InvestorsHub Logo
Followers 335
Posts 19008
Boards Moderated 0
Alias Born 08/25/2007

Re: None

Friday, 11/17/2017 2:34:01 PM

Friday, November 17, 2017 2:34:01 PM

Post# of 2719
New FDA Policy : (Scleroderma Regenerative Drug)

Ways to expedite approvals for regenerative medicines for serious conditions

http://www.raps.org/Regulatory-Focus/News/2017/11/16/28900/FDA-Unveils-New-Regenerative-Medicine-Framework/

Granted FDA Orphan Drug Designation for ECCS-50 in Scleroderma
http://ir.cytori.com/investor-relations/news/news-details/2016/Cytori-Granted-FDA-Orphan-Drug-Designation-for-ECCS-50-in-Scleroderma/default.aspx

DONT LISTEN TO ME IM CANADIANNNNNNNN